They should not exceed 300 words and should be typed double space (d Illness doesn't belong to us (but we'll keep on taking the tablets anyway) Doctors may be reluctant to admit to their own ill health and to seek help from colleagues (September 1997 JRSM, pp491-5) but they commonly prescribe for themselves. Last summer a reunion of former university friends, as well as providing a fossil record of medical student attitudes and humour a quarter of a century ago, offered an opportunity to study the personal pharmaceutical preferences of a cross-section of middle-aged doctors over a continuous 1 1-day period.
Our party set off from St Bee's Head in Cumbria to follow Alfred Wainwright's Coast to Coast Walk to Robin Hood's Bay in North Yorkshire, a distance of some 190 miles. The core group of nine walkers* included four general practitioners, a general surgeon, an anaesthetist, a general physician and a rheumatologist, the other member being non-medical. The group was joined at different stages by a psychiatrist and an orthopaedic surgeon whose skills were required in roughly equal measures.
In addition to pre-existing conditions, the main ailments experienced on the trip were blisters, arthralgias, insect bites, cold sores, foot infections, haemorrhoids and iatrogenic headaches and gut upsets. These were treated with a total of nineteen different oral medications, nine topical applications and one rectal agent. Two of the party were taking regular nutritional supplements including vitamins B12, D, C and E, evening primrose oil, fish oils and calcium wvhilst another was on regular minocycline and one other was on the Pill. Pain was the principal reason for self medication. Paracetamol and co-proxamol were the favourite analgesics, being used by six walkers. The drug taken in greatest quantity, ethanol, was responsible for much of the consumption of analgesics. Amongst the non-steroidal anti-inflammatory drugs (NSAIDs) diclofenac (five users) wras more popular than ibuprofen (three) or meloxicam (one), although the Arthrotec preparation incorporating misoprostol initially chosen by one walker was abandoned because of socially unacceptable side-effects on the lower bowel. Lansoprazole was marginally preferred to ranitidine for alcoholic dyspepsia. The wettest June for 137 years minimized the need for terfenidine, Opticrom and Beconase but despite lack of sunshine acvclovir was required by two of the party. Other topical agents used included NSAID gels (ibuprofen, ketoprofen, felbinac), hydrocortisone 1% cream and Tri-Adcortyl.
The greatest number of medications used by a single individual was ten, which were introduced via a variety of orifices or smeared on the offending surface. The same walker on his return home underwent a magnetic resonance scan which was normal.
Whilst doctors may deny serious illness in themselves, this evidence indicates not only an acknowledgement of self-induced ill-health but even a willingness to submit to it. N J Sheehan 52 Casewick Lane, Uffington, Stamford, Lincs PE9 4SX, UK
Why do young doctors leave the profession?
With reference to Dr Paice's editorial (August 1997 JRSM, p417) and the subsequent correspondence I would like to add some comments from a junior doctor.
I was brought up to be a doctor from the age of two. In my family I am a third generation doctor. The job that I can look forward to is so different from theirs that I actively discouraged my brother from entering the profession. At my age my grandmother, with three young children, was working as a part-time general practitioner (GP). Her salary paid for the home expenses, nanny, cook, housekeeper and gardener. Mine, a research salary, is on a par with a West End secretary.
The Royal College of Obstetricians and Gynaecologists informed trainees that very few Calman jobs will be available over the next four years. The lack of expansion in consultant numbers is being blamed for this and the aim is to 'encourage' us to become GPs. This is in the same month that GP representatives are asking for a 50% increase in their salary to compensate them for changes in their jobs. It seems to me that just when you have collected all the correct qualifications to move onto the next stage (in my case MA, MB BS with MD and MRCOG to follow shortly) the goal posts are moved and the job no longer exists. The previously unthinkable prospect of unemployed doctors is now a reality. A job description in school careers departments should read: Hyperactive behaviour in children, a syndrome now known as attention deficit hyperactivity disorder (ADHD)l and affecting at least one in twventy in a classroom, was first described in association with the First World War epidemic of von Economo's encephalitis2. In addition to hyperactivity, the children exhibited impulsiveness, irritability, and antisocial behaviour, character-JOURNAL OF THE ROYAL SOCIETY OF MEDICINE Volume 90 December 1997 istic comorbid symptoms of ADHD. This description of behavioural sequelae to an encephalitic illness was followed by reports of similar behavioural syndromes in children that were linked to brain damage or dysfunction'.
ADHD is a heterogeneous disorder with several proposed aetiological factors. These include genetic, familial, environmental, pregnancy related risks (prematurity, asphyxia, cocaine and alcohol abuse), meningitis, encephalitis, head injury, toxins, and drugs. A report of cases of temporal lobe arachnoid cyst, a prenatal developmental lesion, that presented as ADHD3, provides further support for an organic aetiology. Viral illness as a cause of ADHD has recently been emphasized by a study of seasonal variations in the birth patterns of children with ADHD, with a significant first trimester exposure to infection4 and risk of fetal brain damage. Professor Dourmashkin's article lends credence to this hypothesis and should stimulate further investigation of viral illness, especially influenza, during pregnancy and early childhood as a potential and overlooked factor in the cause of the ADHD syndrome. J Gordon Millichap The herbicide paraquat, considered safe for rodents in high doses, was lethal to humans in the most minute doses. This is due to differences in species' ADME (absorption, distribution, metabolism, elimination) rates. More importantly, thousands of drugs and consumer products deemed to be toxic and/or carcinogenic in animals remain in common use. DDT (an animal carcinogen) is still sprayed on bananas in Ecuador and exported back to industrialized countries, leading one to question whether animal test results are taken seriously. Are animal tests scientifically sound? Dr Roe implies that we have leamed about how non-mutagenic compounds, including hormones, can increase the risk of cancer, presumably in animals. But he fails to mention that circulating levels of oestrogen and progesterone differ as much as threefold between rodents and humans. Moreover, the toxic doses observed in rodents and other animals may be completely irrelevant to those observed in humans because the organs that are affected, the types of cancers that are produced, the way in which they metastasize, and the rates at which they manifest themselves, are vastly different. The unrealistically high doses of chemical fed to animals, which cause abnormal biological responses, along with a vast catalogue of interspecies differences, make the study of mutagenesis in animals (and extrapolation to the human situation) difficult, if not impossible. Even more egregious is the fact that the animal tests have never been validated.
Ironically, the discovery that mutation was involved in carcinogenesis relied on simple cell tests in which the mutation process could readily be observed. Positive results in such tests could lead to the speedy removal of toxic substances from the market, instead of waiting to see whether they cause cancer, developmental or other effects. The Multicenter for the Evaluation of In Vitro Cyotoxicity project in Sweden recently announced that in-vitro tests with human cells are more sensitive and reliable predictors of human toxicity than animal studies. These results are based on solid science, not on hope, as Dr Roe alleges.
Studies on volunteers do have a place in testing for risk before the general release of a new substance. Such trials are mandatory before the release of a new drug in the US. And many companies, including Unilever in the UK, are conducting human trials with surfactants to obtain clinically relevant information. Human data have acquired an aura of immorality; yet without them scientists can learn nothing about disease and cannot calculate real risks.
Several non-animal methods, including physiologically based biokinetic models (such as the EDOI model), are also being used to determine dose-response relationships at the molecular, biochemical, cellular and organ system levels, quickly and cheaply, using realistic exposure scenarios. To test the 80000 chemicals currently on the market with standard animal tests would take over 1000 years (and cost some US$380 billion). Ultimately, we must reduce our dependence on synthetic chemicals. 'Improving the quality of tests' that are so scientifically and ethically flawed from the outset is not the answer. 
